| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/20/2008 | EP1889627A1 Therapeutic agent for blood-related disease containing epo derivative |
| 02/20/2008 | EP1889625A1 Dietary supplement for supporting mental and physical performance |
| 02/20/2008 | EP1889623A2 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics |
| 02/20/2008 | EP1888741A2 Treatment of ischemia using stem cells |
| 02/20/2008 | EP1888728A1 Fatty acid analogues, i.e. dha derivatives for uses as a medicament |
| 02/20/2008 | EP1888727A1 New dha derivatives and their use as medicaments |
| 02/20/2008 | EP1888614A2 Process for preparing 3alpha(beta)-7alpha(beta)-dihydroxy-6alpha(beta)-alkyl-5beta-cholanic acid |
| 02/20/2008 | EP1888569A1 Substituted piperidines as renin inhibitors |
| 02/20/2008 | EP1888566A1 2-[(isoquinolin-3-carbonyl)amino]-propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis |
| 02/20/2008 | EP1888546A1 Thiazole derivatives and use thereof |
| 02/20/2008 | EP1888103A2 Use of glp-1, exendin and agonists thereof to delay or prevent cardiac remodeling |
| 02/20/2008 | EP1888076A1 Use of pyrazolopyrimidine against cardiovascular diseases |
| 02/20/2008 | EP1888062A1 The use of rapamycin derivatives for the treatment and/or prevention of cardiovascular disorders |
| 02/20/2008 | EP1888049A2 Localized delivery of cardiac inotropic agents |
| 02/20/2008 | EP1572211B1 Therapeutic applications of 2-substituted 4-heteroarylpyrimidines |
| 02/20/2008 | EP1458389B1 Aqueous solutions of moxaverin for the treatment of erectile dysfunction |
| 02/20/2008 | EP1424907B1 Oil composition |
| 02/20/2008 | EP1406667B1 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 02/20/2008 | EP1383747B1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 02/20/2008 | EP1372637B1 Premixed amiodarone parenteral solution and method for making the same |
| 02/20/2008 | EP1354871B1 Biphenyl derivatives |
| 02/20/2008 | EP1225915B1 Use of anti-il-2 polyclonal antibodies for the treatment of insulin-dependent diabetes mellitus and lupus erythematosus |
| 02/20/2008 | EP1166784B1 Inhibition of vascular restenosis after angioplasty |
| 02/20/2008 | EP1064010B1 Peptide compositions and formulations and use of same |
| 02/20/2008 | EP0975347B1 Synergistic combination of pde inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists |
| 02/20/2008 | EP0644877B1 Substituted-hexahydrobenzo a phenanthridines |
| 02/20/2008 | CN101128485A Monoclonal antibodies against angiopoietin-like protein 4 (ANGPTL4) |
| 02/20/2008 | CN101128484A Compositions and methods relating to anti IGF-1 receptor antibodies |
| 02/20/2008 | CN101128473A Adenosine derivatives having a2a receptor activity |
| 02/20/2008 | CN101128430A Pyridine compounds for the treatment of prostaglandin mediated diseases |
| 02/20/2008 | CN101128428A Novel pyridine derivatives as potassium ion channel openers |
| 02/20/2008 | CN101128197A Preventive or therapeutic agent for cardiac dysfunction or myocardial damage caused by ischemia or ischemia-reperfusion |
| 02/20/2008 | CN101126105A Method for preparing antihypertensive peptides by using rice separated protein |
| 02/20/2008 | CN101125846A Preparation method for medicament compound brasilein and use thereof |
| 02/20/2008 | CN101125836A Costene lactone derivative and medical use thereof |
| 02/20/2008 | CN101125198A Application of HSP27 in aspect for improving post-ischemic cardiac systolic function |
| 02/20/2008 | CN101125164A Blood-pressure-lowering and blood-lipid-lowering compound apocynum leaf solid preparation and preparation method thereof |
| 02/20/2008 | CN101125159A Medicine for treating hemorrhoid, anal fissure and anal fistula |
| 02/20/2008 | CN101125157A Medicine for curing coronary heart disease |
| 02/20/2008 | CN101125146A Medicine target for preventing and treating cardiovascular and cerebrovascular diseases associated with inflammation and its inhibitor |
| 02/20/2008 | CN101125143A Hypertension-treating compound medicine |
| 02/20/2008 | CN101125123A Red sage root A magnesium injection preparation and preparation method thereof |
| 02/20/2008 | CN101124991A Health-care bag beverage capable of preventing high blood pressure |
| 02/20/2008 | CN100370019C Lactobacillus plantarum CW006 with antihypertensive function |
| 02/20/2008 | CN100369919C Tricyclic protein kinase inhibitors |
| 02/20/2008 | CN100369917C Himbacine analogues as thrombin receptor antagonists |
| 02/20/2008 | CN100369914C 3-ene-8-ethyl-2,7,12,15,18-pentamethyl-13-carboxylic acid-17-propionic acid amino acid amide, its synthetic method and light power therapeutic medicine |
| 02/20/2008 | CN100369898C Nicotinamide derivates useful as p38 inhibitors |
| 02/20/2008 | CN100369894C Nitric oxide synthase inhibitor phosphate salt |
| 02/20/2008 | CN100369891C HIF hydroxylase inhibitors |
| 02/19/2008 | US7332608 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents; synthesis |
| 02/19/2008 | US7332579 Antiproliferative agents; anticancer agents |
| 02/19/2008 | US7332523 TNP-470 polymer conjugates and use thereof |
| 02/19/2008 | US7332521 Substituted indoles |
| 02/19/2008 | US7332517 1-(1H-indol-3-ylmethyl)-3-(4-nitrophenyl)-5-[2-(4-phenyl-1H-imidazol-2-yl)ethyl]-2thioxo-4imidazolidinone; somastatin receptor affinity; acromegaly, hypophyseal adenomas, endocrine gastroenteropancreatic tumors, as carcinoid syndrome and gastrointestinal bleeding |
| 02/19/2008 | US7332515 Indole-amid derivatives which possess glycogen phosphorylase inhibitory activity |
| 02/19/2008 | US7332514 Dibenzylamine compound and medicinal use thereof |
| 02/19/2008 | US7332507 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted |
| 02/19/2008 | US7332498 N-(3-amino-propyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl)-2-methyl-propyl]-4-methyl-benzamide; kinesin spindle protein inhibitor; cell division, mitosis phase arrest; antiproliferative and antiinflammation agent, hyperplasias, restenosis, cardiac hypertrophy, autoimmune disorders |
| 02/19/2008 | US7332497 Pyrazolopyrimidines as therapeutic agents |
| 02/19/2008 | US7332492 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by NP Y5 receptor |
| 02/19/2008 | US7332486 9-(4-carboxyphenyl)-6-cyclopropylamino-2-trifluoromethylpurine; side effect reduction; cognition activator, antidepressants, neuroleptic agent, schizophrenia, Alzheimer's disease, schizophrenia, Parkinson's, Huntington's, Pick's, Creutzfeld-Jakob, cardiovascular diseases, HIV |
| 02/19/2008 | US7332483 3-(5-benzamido-2-chlorophenyl)-7-methoxy-3,4-dihydroquinazolin-4-one;cytokines (tumor necrosis factor and interleukins) inhibitor; antiinflammatory agent, rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease |
| 02/19/2008 | US7332473 derived from a PACAP or VIP peptide; can inhibit tautomerization in a solution; regressive neurodegenerative diseases, erectile dysfunction, and bronchial asthma; inhibited isomerization and high stability during the production and storage |
| 02/19/2008 | US7332301 Insulin-like growth factor binding protein |
| 02/19/2008 | US7332185 Component I selected from alpha acids and beta acids and component II selected from alpha acids, beta acids, essential oils, fats and waxes; specific inhibition of cyclooxygenase-2 with little effect on cyclooxygenase-1 |
| 02/19/2008 | US7332177 Administering melatonin to ameliorate or prevent symptoms of hypertension developing in a patient who is resistant to the antihypertensive effect of an antihypertensive compound |
| 02/19/2008 | CA2481723C 5ht2c receptor modulators |
| 02/19/2008 | CA2328927C Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/19/2008 | CA2304698C Endothelin antagonist and beta receptor blocking agent as combined preparations |
| 02/19/2008 | CA2273240C Compositions and methods for treating or preventing inflammatory diseases |
| 02/19/2008 | CA2259584C Plasters containing isosorbide dinitrate |
| 02/19/2008 | CA2206366C Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 02/19/2008 | CA2173976C Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 02/14/2008 | WO2008019143A2 Use of exendins and glp-i receptor agonists for altering lipoprotein particle size and subclass composition |
| 02/14/2008 | WO2008019106A1 Methods and compositions for the treatment of pulmonary hypertension using a combination of a calcium channel blocker and a phosphodiesterase inhibitor |
| 02/14/2008 | WO2008018843A1 Process for producing useful salts form of biphenyl-tetrazole compounds |
| 02/14/2008 | WO2008018655A1 Novel thiazole-based compound and inhibitor of t-type calcium channel containing the same |
| 02/14/2008 | WO2008018641A1 Monoclonal antibodies against stromal derived factor-1 (sdf-1) |
| 02/14/2008 | WO2008018529A1 Novel pyrimidine compound having benzyl(pyridylmethyl)amine structure and pharmaceutical comprising the compound |
| 02/14/2008 | WO2008018488A1 Antibacterial agent |
| 02/14/2008 | WO2008018450A1 Cell preparation containing multipotential stem cells originating in fat tissue |
| 02/14/2008 | WO2008018427A1 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient |
| 02/14/2008 | WO2008018306A1 Quinazoline derivative |
| 02/14/2008 | WO2008017845A1 Apples with high polyphenolic content |
| 02/14/2008 | WO2008017842A1 Polyphenol extraction process |
| 02/14/2008 | WO2008017685A1 Nitrate esters of piperidines |
| 02/14/2008 | WO2008017637A1 Drug combinations for the treatment of respiratory tract diseases |
| 02/14/2008 | WO2008017586A2 Special carbonyl-bis imino compounds for using as p2y11 receptor agonists in the treatment of immune diseases |
| 02/14/2008 | WO2008017465A1 Bicyclic lactam derivatives, their manufacture and use as pharmaceutical agents |
| 02/14/2008 | WO2008017216A1 The application of marine steroid in preparing the medicine of treating neurons damaging |
| 02/14/2008 | WO2007118680A3 Remedies for ischemia |
| 02/14/2008 | WO2007117560A8 Piperidine and morpholine renin inhibitors |
| 02/14/2008 | WO2007018248A9 Pyridone compound |
| 02/14/2008 | WO2006024627A9 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/14/2008 | US20080039530 treating a mammal for a vascular permeability disorder by administering a vascular endothelial sphingosine-1-phosphate receptor agonist comprising 2-amino-2-[2-(4-octaphenyl)ethyl]propane-1,3 diol, or 2-amino-2-methyl-4-[4-heptoxy-phenyl]butane-1-ol |
| 02/14/2008 | US20080039525 Lipid System and Methods of Use |
| 02/14/2008 | US20080039512 2-methyl-6-[3-(2-phenyloxazol-4-ylmethoxy)propoxymethyl] benzoic acid |
| 02/14/2008 | US20080039489 Tetrahydrofuran derivatives for use as inhibitors of matrix metalloproteinases |
| 02/14/2008 | US20080039484 Methods and Compositions for Preventing or Treating Cardiovascular Disease |